Caveats for triple-H therapy in the management of vasospasm after aneurysmal subarachnoid hemorrhage.
Hunt, Matthew A
Caveats for triple-H therapy in the management of vasospasm after aneurysmal subarachnoid hemorrhage. [electronic resource] - Critical care medicine Aug 2007 - 1985-6 p. digital
Publication Type: Comment; Editorial
0090-3493
10.1097/01.CCM.0000277255.94441.78 doi
Cerebrovascular Circulation--drug effects
Hemodilution--adverse effects
Humans
Plasma Substitutes--adverse effects
Subarachnoid Hemorrhage--therapy
Vasoconstrictor Agents--adverse effects
Vasospasm, Intracranial--therapy
Caveats for triple-H therapy in the management of vasospasm after aneurysmal subarachnoid hemorrhage. [electronic resource] - Critical care medicine Aug 2007 - 1985-6 p. digital
Publication Type: Comment; Editorial
0090-3493
10.1097/01.CCM.0000277255.94441.78 doi
Cerebrovascular Circulation--drug effects
Hemodilution--adverse effects
Humans
Plasma Substitutes--adverse effects
Subarachnoid Hemorrhage--therapy
Vasoconstrictor Agents--adverse effects
Vasospasm, Intracranial--therapy